wwwroyal888casino| The market volume is 864.4 billion yuan, with the number of companies falling to 4,126

The market volume today is 864.4 billion, which is 104.3 billion smaller than that of yesterday, and the northbound capital outflow is 40%.Wwwroyal888casino.40 million. The market rose by 897, fell by 4126, actually rose by the limit of 45, and fell by the limit of 2. Two days ago, the market is always up 3,000 or 4,000, but the market is in a mess. Everything is rising and everything is moving, that is, there is nothing to lead the rise. Today, the number of gainers in the market is less than 900, but it gives a very good money-making effect. There is no particularly big decline and money-loss effect in the falling plate, and there is almost no limit. So I have always stressed that for the short term, the focused market is the good market.

In an in-depth review on the evening of May 5, it was also found that the ebb of the market had ended and the mood began to warm up, and the most suitable sector at this node was still synthetic organisms, and the reason was also written at that time. Hazy, oversold, broad concept, much better than the open-card news-driven real estate and finance, the synthetic biology sector rose 17% in three days this week, and continue to be optimistic about this sector. Index, the Shanghai Stock Exchange is very standard back to the 5th line, while there is a jump gap support, the Shanghai Stock average slowly began to show a long line, gem received 4 negative lines horizontal, but the recent money-making effect is still in the gem speculation.

Emotionally, the old hot spots are gradually clear and their impact on market sentiment is declining sharply, funds prefer low-level new themes and new chips, low-level synthetic organisms and chemical lines have recently stepped out of the sustainable plate, and the market style has basically bid farewell to the pure number board tactics after Ai Seiko (603580) (although there is still, but it has been greatly reduced and basically has no impact on the market). Further transfer to the 20cm trend and connecting board, the fault tolerance rate of the market joint force is still high. To sum up, the point of view has not changed much from yesterday, the index environment is still healthy, and the market continues to focus, and if there are big differences in the next two days, it is still a low suction point for some core identification of the main line. in addition, the new logic in the main line will also have more sufficient buying and flexibility, the fault tolerance rate of the main rise period is relatively high, and it still needs to be bolder.

Market core plateWwwroyal888casino1. Medicine (synthetic biology, regenerative medicine, stem cells, gene therapy), 6 boards: Azure organisms (603739), 2 boards: Jimin Medical treatment, Qianjiang Biochemistry (600796), 4 days 3 boards: Lu Anti-Medicine (600789), 3 days 2 boards: star Lake Science and Technology (600866) Board 1: Shuangcheng Pharmaceutical (002693), Rhine Biological (002166), South China Biological (000518), Vcanbio (600645), Jinan Hi-tech, Nanjing Xinbai (600682), Han Shang Group (600774), Jiu'an Medical (002432), etc., 20cm: Ruifeng High Materials (300243), Common Pharmaceutical, Guanhao Biology (300238), David Medical (300314), Kaineng Health (300272), Tailin Biology, Xiangxue Pharmaceutical (300147), 30cm: Bawei shares. 2. Chemical industry, 4 boards: Baichuan shares (002455), Societe Generale shares (603928), 3 boards: Lily (603823), 2 boards: Hubei Yihua, 1 board: Lanfeng biochemical (002513), Asia-Pacific Industries (000691), Glinda.

According to McKinsey, synthetic biology will have an economic impact of $2 trillion to $4 trillion in the future on materials, chemicals and energy, human health and performance, agriculture, aquaculture and food, consumer goods and services. 2) according to the White Paper on China's synthetic Biology Industry 2024, it is expected that the global synthetic biological market will maintain a rapid development momentum in the foreseeable future and will grow into a global market with a volume of nearly 50 billion US dollars in 2028. 3) the Letters Patent team of Shanghai Changzheng Hospital and Cheng Xin team of the Chinese Academy of Sciences have successfully cured a type 2 diabetic patient with severely impaired islet function by using autologous regenerated islet transplantation derived from stem cells for the first time in the world. At present, the patient has been completely free from insulin for 33 months. The relevant results were published in the international journal Cell Discovery. 4) Clinical trials show that gene editing therapy can improve the vision of patients with hereditary blindness.